AHA today urged the Drug Enforcement Administration to release its proposed rules outlining a special registration process for prescribing medically necessary controlled substances via telehealth after the COVID-19 public health emergency; provide an interim plan to support continuity of care if the PHE expires before the rules are finalized; and grant a permanent exception for separate registrations for practitioners in states that have medical licensing reciprocity requirements.

“[T]here is growing concern that the pending expiration of the COVID-19 PHE and its associated waivers, combined with the lack of a special registration regulation, will leave providers in a position where they will need to cut services and leave patients without access to necessary treatment,” AHA wrote. “With the expiration of the COVID-19 PHE currently scheduled for next year, this situation could come to pass as early as mid-January.”

Related News Articles

Headline
Hospitals may continue to bill through calendar year 2023 for certain outpatient physical therapy, occupational therapy, speech language pathology services,…
Headline
Telehealth Access for America, an AHA-supported campaign to protect patient access to critical telehealth services, urged Congress to make permanent certain…
Headline
As urged by the AHA, the Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration released a temporary rule …
Headline
HIPAA enforcement discretion implemented for the COVID-19 public health emergency will expire with the end of the PHE on May 11, but covered health care…
Headline
Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study…
Headline
The Drug Enforcement Administration Friday proposed limiting telehealth prescriptions for buprenorphine and other controlled substances after the…